Overview

Update
IPO / Stock
Went Public on May 6, 2015 / NASDAQ:LIFE
Total Equity Funding
$170.5M in 5 Rounds from 5 Investors
Headquarters:
San Diego, CA
Description:
aTyr Pharma discovers and develops protein biologics for human therapeutics.
Founders:
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.atyrpharma.com
Social:

Company Details

Update

aTyr Pharma develops biologic therapeutics based on Physiocrine biology. aTyr has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Funding Rounds (6) - $180.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2015$76M / Series E1
Jul, 2013$10M / Debt Financing1
Jul, 2013$49M / Series D4
Oct, 2010$23M / Series C4
Sep, 2009$12M / Series C3
Apr, 2007$10.5M / Series B3

Current Team (9)

Update

Offices/Locations (1)

Update
  • HQ

    3565 General Atomics Ct

    Suite 103

    San Diego, CA 92121

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos